Inovise Medical

Focus: Inovise Medical is a early-stage cardiovascular biotech company founded in 2020, focused on cardiac function monitoring technologies and heart failure interventions. Based in Beaverton, Oregon, the company operates as a pre-revenue biotech with a specialized pipeline in cardiac monitoring and neuromodulation approaches.

Cardiovascular

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Inovise Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Inovise Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE

Acute Heart Failure

N/A

Phrenic nerve stimulation

Heart Failure, Congestive

N/A

Clinical Trials (1)

Help build intelligence for Inovise Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to shape early-stage company culture and IP at a cardiovascular-focused biotech with emerging technologies in cardiac monitoring
Focused therapeutic area (cardiovascular) with clear unmet need in acute heart failure management and congestive heart failure treatment
Early-stage ownership potential: pre-commercial phase allows for high individual impact on clinical trial design, regulatory strategy, and company direction

Watch Out For

No active job openings listed (activeJobCount: 0) suggests company may not be actively hiring or is in stealth/limited scaling phase
Pre-revenue status with unknown funding levels and employee count creates significant uncertainty around salary, benefits, and financial runway stability
Early-stage pipeline with only 3 total clinical trials and no advanced-phase programs (no Phase 2/3 data) means limited near-term catalysts or commercial value realization

Generated by Claude from Inovise Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT00541541Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation

N/A

Doppler-echocardiography and acoustic cardiography

Heart Failure, Congestive

N/A

Clinical Trials (1)

NCT00541801Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography

N/A

Stimulation of the diaphragm

Heart Failure

N/A

Clinical Trials (1)

NCT00769678Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2020

Portfolio: 3 clinical trials

Top TAs: Cardiovascular

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Cardiovascular

3 pipeline

Marketed

Pipeline